Genetic Polymorphisms in Follicular Helper T Cell-Related Molecules Predispose Patients to De Novo Donor-Specific Antibody Formation After Kidney Transplantation.
暂无分享,去创建一个
H. Ohdan | Yuka Tanaka | K. Ide | N. Tanimine | H. Sakai | M. Ohira | H. Tahara | Kosuke Ono | R. Nakano
[1] H. Ohdan,et al. Polymorphisms in CTLA-4 predict de novo donor specific antibody formation after kidney transplantation. , 2022, Human immunology.
[2] H. Rennke,et al. Follicular T cells mediate donor‐specific antibody and rejection after solid organ transplantation , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] V. Venturi,et al. Tfh Cells in Health and Immunity: Potential Targets for Systems Biology Approaches to Vaccination , 2020, International journal of molecular sciences.
[4] M. Ford,et al. Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor‐specific antibody formation after transplantation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] S. Crotty. T Follicular Helper Cell Biology: A Decade of Discovery and Diseases. , 2019, Immunity.
[6] D. Lora,et al. Longitudinal profile of circulating T follicular helper lymphocytes parallels anti‐HLA sensitization in renal transplant recipients , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] R. Förster,et al. T cell specific Cxcr5 deficiency prevents rheumatoid arthritis , 2017, Scientific Reports.
[8] N. Goto,et al. De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury , 2016, Transplantation.
[9] H. Ohdan,et al. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation. , 2016, Human immunology.
[10] L. Walker,et al. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement , 2014, Proceedings of the National Academy of Sciences.
[11] S. Crotty. T follicular helper cell differentiation, function, and roles in disease. , 2014, Immunity.
[12] M. McCrae,et al. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine. , 2014, Vaccine.
[13] F. Shi,et al. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis , 2014, Diagnostic Pathology.
[14] G. Ghiggeri,et al. Posttransplant De Novo Donor‐Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody‐Mediated Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] P. Nickerson,et al. Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] S. Crotty,et al. Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.
[17] R. Marcén,et al. Immunosuppressive Drugs in Kidney Transplantation , 2009, Drugs.
[18] J. Cyster,et al. Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation1 , 2007, The Journal of Immunology.
[19] T. Dryja. Deficiencies in sight with the candidate gene approach , 1990, Nature.
[20] Weifeng Tang,et al. Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto’s thyroiditis susceptibility: a meta-analysis , 2014 .